Company Overview
Teladoc Health, Inc. delivers virtual healthcare services to patients globally, operating primarily through its Teladoc Health Integrated Care and BetterHelp segments. The company focuses on providing integrated care solutions that include general medical consultations, expert medical services, specialty medical support, and management of chronic conditions. This entity operates within the Healthcare sector, specifically classified under the Health Information Services industry, positioning it at the intersection of medical delivery and digital information platforms. The company holds a market capitalization of $965.12M and generated annual revenue of $2.53B, supported by a workforce of 4,648 employees. These financial figures indicate that while the company maintains a substantial operational footprint with nearly half a million dollars in revenue per employee, its market valuation reflects a specific investor sentiment regarding its growth trajectory and profitability challenges in the current economic environment.
Financial Health
The company reported a trailing twelve-month revenue of $2.53B, yet simultaneously recorded a net income loss of $200,322,000, alongside an EBITDA of $33.06M. The significant disparity between the positive revenue figure and the negative net income reveals a cost structure where operational expenses and taxes exceed gross profits, resulting in a net loss despite the generation of earnings before interest, taxes, depreciation, and amortization. Despite the reported net loss, the company generated free cash flow of $226.14M, which provides a critical buffer for financial flexibility and the ability to fund operations without relying solely on external financing. Profitability analysis shows a gross margin of 69.5%, indicating high efficiency in cost of goods sold, contrasted sharply by an operating margin of -4.2% and a profit margin of -7.9%, which signals that overhead costs and other expenses are eroding the majority of the gross profit. Regarding liquidity and leverage, the company holds cash reserves of $781.08M against total debt of $1.04B, resulting in a debt-to-equity ratio of 75.06 that suggests a highly leveraged balance sheet. However, the current ratio stands at 2.77, indicating that the company possesses more than double the liquid assets required to cover its short-term liabilities. Return metrics further illustrate the financial pressure, with a return on equity of -13.9% and a return on assets of -3.2%, revealing that management has not yet generated positive returns on the capital invested in the business or the assets employed.
Valuation Assessment
Valuation metrics present a mixed picture, with a trailing P/E ratio listed as N/A due to the lack of positive earnings, while the forward P/E is recorded at -6.35. The difference between a non-existent trailing P/E and a negative forward P/E implies that the market is pricing in expectations for future earnings improvement, although the negative forward multiple technically suggests the market anticipates continued losses or a significant turnaround in profitability is required to reach positive valuations. The price-to-book ratio is 0.70, which indicates that the stock is trading at a discount relative to its book value, suggesting the market may be undervaluing the company's tangible assets or expecting future value destruction. Alternative valuation metrics include a price-to-sales ratio of 0.38 and an EV/EBITDA of 36.70, which suggest that the company is valued cheaply relative to sales but expensively relative to its EBITDA, highlighting the disconnect between revenue generation and cash flow conversion in the eyes of the market. In terms of trading range, the 52-week high was $9.77 and the 52-week low was $4.40, meaning the current market price sits within a range that reflects significant volatility over the past year. The stock exhibits a beta of 2.19, which signifies that the share price is highly sensitive to market movements, typically moving with more than twice the magnitude of the broader market index.
Growth & Income
Growth metrics show a revenue growth year-over-year of 0.3%, while earnings growth is listed as N/A due to the company's lack of net income. The absence of positive earnings growth combined with stagnant revenue growth implies that the company is currently in a stabilization phase rather than a high-growth expansion phase, where operating leverage has not yet translated into profitability. Regarding income distribution, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. This lack of a dividend payout indicates that the company retains all of its earnings, or in this case, its cash flows, to reinvest into the business for growth or to service its substantial debt obligations rather than distributing returns to shareholders. The overall growth and income profile is characterized by minimal revenue expansion and a complete reliance on capital preservation and operational restructuring to eventually achieve a profitable status, rather than providing current income through dividends or consistent earnings growth.